The phosphatidylinositol 3-Kinase AKT pathway in human cancer - PubMed (original) (raw)

Review

doi: 10.1038/nrc839.

Affiliations

• PMID: 12094235
• DOI: 10.1038/nrc839

Review

The phosphatidylinositol 3-Kinase AKT pathway in human cancer

Igor Vivanco et al. Nat Rev Cancer. 2002 Jul.

No abstract available

PubMed Disclaimer

Similar articles

• The phosphoinositide 3-kinase pathway.
  Cantley LC. Cantley LC. Science. 2002 May 31;296(5573):1655-7. doi: 10.1126/science.296.5573.1655. Science. 2002. PMID: 12040186 Review.
• Targeting the PI3K-Akt pathway in human cancer: rationale and promise.
  Luo J, Manning BD, Cantley LC. Luo J, et al. Cancer Cell. 2003 Oct;4(4):257-62. doi: 10.1016/s1535-6108(03)00248-4. Cancer Cell. 2003. PMID: 14585353 Review. No abstract available.
• Introduction: multifaceted roles of lipids and their catabolites in immune cell signaling.
  Ott VL, Cambier JC. Ott VL, et al. Semin Immunol. 2002 Feb;14(1):1-6. doi: 10.1006/smim.2001.0336. Semin Immunol. 2002. PMID: 11884225 Review. No abstract available.
• Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance.
  Campbell RA, Bhat-Nakshatri P, Patel NM, Constantinidou D, Ali S, Nakshatri H. Campbell RA, et al. J Biol Chem. 2001 Mar 30;276(13):9817-24. doi: 10.1074/jbc.M010840200. Epub 2001 Jan 3. J Biol Chem. 2001. PMID: 11139588
• The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase.
  Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PN. Franke TF, et al. Cell. 1995 Jun 2;81(5):727-36. doi: 10.1016/0092-8674(95)90534-0. Cell. 1995. PMID: 7774014

Cited by

• Understanding the molecular regulatory mechanisms of autophagy in lung disease pathogenesis.
  Lin L, Lin Y, Han Z, Wang K, Zhou S, Wang Z, Wang S, Chen H. Lin L, et al. Front Immunol. 2024 Oct 31;15:1460023. doi: 10.3389/fimmu.2024.1460023. eCollection 2024. Front Immunol. 2024. PMID: 39544928 Free PMC article. Review.
• Identification of novel inhibitors targeting PI3Kα via ensemble-based virtual screening method, biological evaluation and molecular dynamics simulation.
  Zhang H, Qi HZ, Li YJ, Shi XY, Hu ML, Chen XL, Li Y. Zhang H, et al. J Comput Aided Mol Des. 2024 Nov 11;38(1):37. doi: 10.1007/s10822-024-00580-2. J Comput Aided Mol Des. 2024. PMID: 39528618
• Discovery of _N_-substituted-2-oxoindolin benzoylhydrazines as c-MET/SMO modulators in EGFRi-resistant non-small cell lung cancer.
  Tomassi S, Natale B, Roggia M, Amato L, De Rosa C, Della Corte CM, Baglini E, Amendola G, Messere A, Di Maro S, Barresi E, Da Settimo F, Trincavelli ML, Ciardiello F, Taliani S, Morgillo F, Cosconati S. Tomassi S, et al. RSC Med Chem. 2024 Oct 3. doi: 10.1039/d4md00553h. Online ahead of print. RSC Med Chem. 2024. PMID: 39512947 Free PMC article.
• Anticancer effect of the oncolytic Newcastle disease virus harboring the PTEN gene on glioblastoma.
  Kim S, Jung BK, Kim J, Jeon JH, Kim M, Jang SH, Kim CS, Jang H. Kim S, et al. Oncol Lett. 2024 Oct 16;29(1):6. doi: 10.3892/ol.2024.14752. eCollection 2025 Jan. Oncol Lett. 2024. PMID: 39492938 Free PMC article.
• Novel quinoline-4-carboxamide derivatives potentiates apoptosis by targeting PDK1 to overcome chemo-resistance in colorectal cancer: Theoretical and experimental results.
  V S, N PA, Kachigere B H, D C VK, Gowda D, B S C, M Srinivasa S, Rangappa S, Rangappa KS. V S, et al. Heliyon. 2024 Sep 19;10(19):e38105. doi: 10.1016/j.heliyon.2024.e38105. eCollection 2024 Oct 15. Heliyon. 2024. PMID: 39386832 Free PMC article.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group

• Other Literature Sources

  • The Lens - Patent Citations Database

• Miscellaneous

  • NCI CPTAC Assay Portal